278 related articles for article (PubMed ID: 28440002)
1. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
Diener SA; Breimhorst M; Vogt T; Krämer HH; Drummond PD; Geber C; Birklein F
Eur J Pain; 2017 Sep; 21(8):1326-1335. PubMed ID: 28440002
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
Tugnoli V; Capone JG; Eleopra R; Quatrale R; Sensi M; Gastaldo E; Tola MR; Geppetti P
Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
[TBL] [Abstract][Full Text] [Related]
4. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
Gazerani P; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2006 Jun; 122(3):315-325. PubMed ID: 16677761
[TBL] [Abstract][Full Text] [Related]
5. Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.
Geber C; Fondel R; Krämer HH; Rolke R; Treede RD; Sommer C; Birklein F
J Pain; 2007 Jun; 8(6):503-14. PubMed ID: 17434803
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F
J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949
[TBL] [Abstract][Full Text] [Related]
7. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia.
Baumann TK; Simone DA; Shain CN; LaMotte RH
J Neurophysiol; 1991 Jul; 66(1):212-27. PubMed ID: 1919668
[TBL] [Abstract][Full Text] [Related]
8. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin.
Sumikura H; Andersen OK; Drewes AM; Arendt-Nielsen L
Pain; 2003 Sep; 105(1-2):285-91. PubMed ID: 14499446
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.
Voller B; Sycha T; Gustorff B; Schmetterer L; Lehr S; Eichler HG; Auff E; Schnider P
Neurology; 2003 Oct; 61(7):940-4. PubMed ID: 14557564
[TBL] [Abstract][Full Text] [Related]
10. Intradermal injection of Botulinum toxin type A alleviates infraorbital nerve constriction-induced thermal hyperalgesia in an operant assay.
Kumada A; Matsuka Y; Spigelman I; Maruhama K; Yamamoto Y; Neubert JK; Nolan TA; Watanabe K; Maekawa K; Kamioka H; Yamashiro T; Kuboki T; Oguma K
J Oral Rehabil; 2012 Jan; 39(1):63-72. PubMed ID: 21793870
[TBL] [Abstract][Full Text] [Related]
11. Flare and hyperalgesia after intradermal capsaicin injection in human skin.
Serra J; Campero M; Ochoa J
J Neurophysiol; 1998 Dec; 80(6):2801-10. PubMed ID: 9862885
[TBL] [Abstract][Full Text] [Related]
12. The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging.
Lo Vecchio S; Andersen HH; Arendt-Nielsen L
Exp Brain Res; 2018 Aug; 236(8):2231-2244. PubMed ID: 29845449
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
Wallace MS; Quessy S; Schulteis G
Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
[TBL] [Abstract][Full Text] [Related]
14. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
Lam VY; Wallace M; Schulteis G
J Pain; 2011 Mar; 12(3):323-30. PubMed ID: 20889387
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.
Blersch W; Schulte-Mattler WJ; Przywara S; May A; Bigalke H; Wohlfarth K
J Neurol Sci; 2002 Dec; 205(1):59-63. PubMed ID: 12409185
[TBL] [Abstract][Full Text] [Related]
16. Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.
Baumgärtner U; Magerl W; Klein T; Hopf HC; Treede RD
Pain; 2002 Mar; 96(1-2):141-51. PubMed ID: 11932070
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.
Paterson K; Lolignier S; Wood JN; McMahon SB; Bennett DL
Ann Neurol; 2014 Apr; 75(4):591-6. PubMed ID: 24550077
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of High-Frequency Electrical Stimulation Following Sensitization With Capsaicin.
Jutzeler CR; Curt A; Kramer JL
J Pain; 2015 Jul; 16(7):595-605. PubMed ID: 25866256
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models.
Marinelli S; Luvisetto S; Cobianchi S; Makuch W; Obara I; Mezzaroma E; Caruso M; Straface E; Przewlocka B; Pavone F
Neuroscience; 2010 Nov; 171(1):316-28. PubMed ID: 20826198
[TBL] [Abstract][Full Text] [Related]
20. A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain.
Wang J; Casals-Diaz L; Zurawski T; Meng J; Moriarty O; Nealon J; Edupuganti OP; Dolly O
Neuropharmacology; 2017 May; 118():223-232. PubMed ID: 28347837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
